HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of vascular dementia: evidence from trials with non-cholinergic drugs.

Abstract
A considerable number of therapeutic trials have been performed in vascular dementia (VaD). The results of these trials have generally been considered as disappointing and no drug treatment has been so far approved for the treatment of VaD by regulatory agencies. The aim of the present paper is to critically review the results of randomized clinical trials performed with non-cholinergic drugs in VaD. The conclusions of the present review are that: (1) some drugs such as nicergoline, memantine, posatirelin, propentofylline, and pentoxifylline have shown some, although partly limited, benefits in VaD patients; (2) besides a lack of efficacy of the tested drugs, possible causes of the negative results of many randomized clinical trials in VaD are the enrollment of patients with heterogeneous subtypes of VaD, the small sample size, and the use of end-points and cognitive tests inadequate for the VaD setting because derived from previous experience in the field of Alzheimer disease. Preliminary analyses show that focusing therapeutic trials on specific forms of VaD such as the subcortical type may lead to results different from those obtained in a heterogeneous VaD group. This selective focus seems to be better suited for disclosing specific treatments in the field of VaD.
AuthorsLeonardo Pantoni
JournalJournal of the neurological sciences (J Neurol Sci) Vol. 226 Issue 1-2 Pg. 67-70 (Nov 15 2004) ISSN: 0022-510X [Print] Netherlands
PMID15537523 (Publication Type: Journal Article, Review)
Chemical References
  • Ergot Alkaloids
  • Nootropic Agents
  • Platelet Aggregation Inhibitors
  • Vasodilator Agents
Topics
  • Dementia, Vascular (drug therapy, psychology)
  • Ergot Alkaloids (therapeutic use)
  • Humans
  • Nootropic Agents (therapeutic use)
  • Platelet Aggregation Inhibitors (therapeutic use)
  • Randomized Controlled Trials as Topic
  • Vasodilator Agents (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: